Overland Storage Inc (NASDAQ:OVRL) currently has a Zacks Rank #4 (Sell). Overland Storage Inc (NASDAQ:OVRL) stock performance was -5.12% in last session and finished the day at $3.52. Traded volume was 151,195.00million shares in the last session and the average volume of the stock remained 71.69K shares. The beta of the stock remained 1.15. Overland Storage Inc (NASDAQ:OVRL) insider ownership is 8.70%.

Zhone Technologies, Inc. (NASDAQ:ZHNE), a global leader in fiber network access solutions (FTTx), on 30 May 2014 announced a new deployment with ESCO Technologies, LLC that provides senior living facilities with state-of-the-art technology to enable better care and more independence for residents. According to The Fiscal Times, there are 76 million baby boomers in the U.S. and the youngest of those will start turning 50 this year. Zhone Technologies Inc (NASDAQ:ZHNE) dropped -5.03 percent to $3.02 Wednesday on volume of 189,927.00million shares. The intra-day range of the stock was $2.99 to $3.18. Zhone Technologies Inc (NASDAQ:ZHNE) has a market capitalization of $97.64million.

Zeldes Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm has commenced an investigation into Prana Biotechnology Limited (ADR) (NASDAQ:PRAN). The investigation is related to potential violations of federal securities laws and other violations. Prana Biotechnology researches and develops therapeutic drugs for the treatment of neurological disorders. The Company’s product line includes PBT2, which is in Phase II clinical trials for the treatment of Alzheimer’s disease. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN)’s stock on June 03, 2014 reported a decrease of -5.52% to the closing price of $1.71. Its fifty two weeks range is $1.47 -$13.29. The total market capitalization recorded $71.22million. The overall volume in the last trading session was 820,819.00million shares. In its share capital, PRAN has 47.15million outstanding shares.

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company focused on the development of innovative approaches to targeting and treating cancer, announced today that Chief Executive Officer Mark Baker will present on Thursday, June 5th, at 10:00 AM EDT at the Jefferies Global Healthcare Conference in New York City. On Wednesday, shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) dropped -5.51% to close the day at $3.43. Company return on investment (ROI) is -53.80% and its monthly performance is recorded as -7.55%. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) quarterly revenue growth is -29.86%.

Mecox Lane Limited (NASDAQ:MCOX), a multi-brand and multi-channel retailer of apparel and accessories in China, on 21 May 2014 announced that its annual general meeting (“AGM”) will be held on Thursday, June 5, 2014 at 10:00 AM (Hong Kong time) at the 18th Floor, One Exchange Square, 8 Connaught Place, Central, Hong Kong. Mecox Lane Ltd (NASDAQ:MCOX) stock performance was -7.96% in last session and finished the day at $4.51. Traded volume was 19,352.00million shares in the last session and the average volume of the stock remained 28.52K shares. The beta of the stock remained 2.58. Mecox Lane Ltd (NASDAQ:MCOX) insider ownership is 0.43%.